rs2457533

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001009944.3(PKD1):​c.7165T>C​(p.Leu2389Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,378,590 control chromosomes in the GnomAD database, including 18,957 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 7297 hom., cov: 30)
Exomes 𝑓: 0.094 ( 11660 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.26

Publications

11 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
MIR6511B1 (HGNC:50228): (microRNA 6511b-1) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 16-2106849-A-G is Benign according to our data. Variant chr16-2106849-A-G is described in ClinVar as Benign. ClinVar VariationId is 256997.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.26 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.506 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.7165T>C p.Leu2389Leu synonymous_variant Exon 17 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.7165T>C p.Leu2389Leu synonymous_variant Exon 17 of 46 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.268
AC:
40243
AN:
150008
Hom.:
7270
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.511
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.284
Gnomad EAS
AF:
0.0317
Gnomad SAS
AF:
0.125
Gnomad FIN
AF:
0.239
Gnomad MID
AF:
0.264
Gnomad NFE
AF:
0.176
Gnomad OTH
AF:
0.262
GnomAD2 exomes
AF:
0.143
AC:
27649
AN:
192938
AF XY:
0.140
show subpopulations
Gnomad AFR exome
AF:
0.471
Gnomad AMR exome
AF:
0.105
Gnomad ASJ exome
AF:
0.248
Gnomad EAS exome
AF:
0.0207
Gnomad FIN exome
AF:
0.190
Gnomad NFE exome
AF:
0.141
Gnomad OTH exome
AF:
0.173
GnomAD4 exome
AF:
0.0943
AC:
115809
AN:
1228468
Hom.:
11660
Cov.:
30
AF XY:
0.0944
AC XY:
58085
AN XY:
615468
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.397
AC:
8929
AN:
22482
American (AMR)
AF:
0.0908
AC:
3787
AN:
41688
Ashkenazi Jewish (ASJ)
AF:
0.214
AC:
4764
AN:
22306
East Asian (EAS)
AF:
0.0347
AC:
1364
AN:
39334
South Asian (SAS)
AF:
0.0891
AC:
7155
AN:
80260
European-Finnish (FIN)
AF:
0.205
AC:
7307
AN:
35666
Middle Eastern (MID)
AF:
0.186
AC:
651
AN:
3494
European-Non Finnish (NFE)
AF:
0.0807
AC:
75125
AN:
930674
Other (OTH)
AF:
0.128
AC:
6727
AN:
52564
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.372
Heterozygous variant carriers
0
4869
9738
14606
19475
24344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1616
3232
4848
6464
8080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.269
AC:
40313
AN:
150122
Hom.:
7297
Cov.:
30
AF XY:
0.265
AC XY:
19432
AN XY:
73274
show subpopulations
African (AFR)
AF:
0.511
AC:
20562
AN:
40206
American (AMR)
AF:
0.191
AC:
2904
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
0.284
AC:
977
AN:
3446
East Asian (EAS)
AF:
0.0314
AC:
162
AN:
5156
South Asian (SAS)
AF:
0.124
AC:
593
AN:
4780
European-Finnish (FIN)
AF:
0.239
AC:
2500
AN:
10444
Middle Eastern (MID)
AF:
0.271
AC:
79
AN:
292
European-Non Finnish (NFE)
AF:
0.176
AC:
11882
AN:
67640
Other (OTH)
AF:
0.259
AC:
540
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1180
2360
3540
4720
5900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.227
Hom.:
925
Bravo
AF:
0.281

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 27, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22608885) -

Polycystic kidney disease, adult type Benign:1
Jul 07, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The c.7165T>C , p.Leu2389Leu variant was identified in 18.75% of 8483 control alleles in the Exome Aggregation Consortium (March 14, 2016). According to ACMG guidelines for variant classification based on allele frequency, category BA1, this variant is considered benign and has not been further reviewed (Richards 2015). -

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
7.7
DANN
Benign
0.43
PhyloP100
3.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2457533; hg19: chr16-2156850; COSMIC: COSV51921397; COSMIC: COSV51921397; API